🇺🇸 Increlex in United States

FDA authorised Increlex on 30 August 2005

Marketing authorisations

FDA — authorised 30 August 2005

  • Application: BLA021839
  • Marketing authorisation holder: IPSEN INC
  • Status: approved

FDA

  • Status: approved

Increlex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Increlex approved in United States?

Yes. FDA authorised it on 30 August 2005; FDA has authorised it.

Who is the marketing authorisation holder for Increlex in United States?

IPSEN INC holds the US marketing authorisation.